{"id":328681,"date":"2025-10-24T08:37:20","date_gmt":"2025-10-24T08:37:20","guid":{"rendered":"https:\/\/www.europesays.com\/us\/328681\/"},"modified":"2025-10-24T08:37:20","modified_gmt":"2025-10-24T08:37:20","slug":"this-ai-method-could-turbocharge-the-hunt-for-new-medicines","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/328681\/","title":{"rendered":"This AI method could turbocharge the hunt for new medicines"},"content":{"rendered":"<p> <img decoding=\"async\" class=\"figure__image\" alt=\"A robot is seen in a bright lab while two people walk past behind a window in the background\" loading=\"lazy\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/d41586-025-03441-6_51605464.jpg\"\/><\/p>\n<p class=\"figure__caption u-sans-serif\">An artificial-intelligence method that incorporates gene-expression data could help to speed up drug discovery.Credit: Qilai Shen\/Bloomberg\/Getty<\/p>\n<p>An artificial intelligence (AI) model trained on complex data from human cells could provide a shortcut in the race to develop new drugs<a href=\"#ref-CR1\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">1<\/a>.<\/p>\n<p>The approach, published on 23 October in Science, builds on <a href=\"https:\/\/www.nature.com\/articles\/d41586-025-00602-5\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-025-00602-5\" data-track-category=\"body text link\" target=\"_blank\" rel=\"noopener\">a trend that is sweeping the field of drug discovery: the use of AI<\/a> to speed up the tedious process of trawling through massive collections of chemical compounds in search of those that could become the next big therapy.<\/p>\n<p>\u201cIt\u2019s a powerful blueprint for the future,\u201d says Hongkui Deng, a cell biologist at Peking University in Beijing, who was not involved in the work. \u201cIt creates a \u2018smart\u2019 screening system that learns from its own experiments.\u201d<\/p>\n<p>Tedious method<\/p>\n<p>For decades, researchers have searched for drugs by working their way through large chemical libraries, testing each compound\u2019s effect on cells that are grown in the laboratory. The approach has had success, identifying drugs that kill cancer cells, for example. <\/p>\n<p>Increasingly, researchers are dreaming of more complex screening methods that could harness the past decade\u2019s explosion in <a href=\"https:\/\/www.nature.com\/articles\/d41586-021-01994-w\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-021-01994-w\" data-track-category=\"body text link\" target=\"_blank\" rel=\"noopener\">genomic data collected from individual cells<\/a>. Such methods could, in theory, evaluate how compounds perturb entire networks of gene activity \u2014 a test that could open new avenues for drug discovery.<\/p>\n<p>But, researchers typically screen tens of thousands of compounds or more for drug discovery, says Alex Shalek, a biomedical engineer at the Massachusetts Institute of Technology in Cambridge. And it would be too expensive and laborious to integrate such large screens with complex assays, he says.<\/p>\n<p><a href=\"https:\/\/www.nature.com\/articles\/d41586-020-00018-3\" class=\"u-link-inherit\" data-track=\"click\" data-track-label=\"recommended article\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"recommended__image\" alt=\"\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/d41586-025-03441-6_18291218.jpg\"\/><\/p>\n<p class=\"recommended__title u-serif\">Powerful antibiotics discovered using AI<\/p>\n<p><\/a><\/p>\n<p>To find a tractable way of harnessing newly available genomic data, Shalek teamed up with other researchers and Cellarity, a biotechnology company in Somerville, Massachusetts. (Shalek is also a paid consultant for the company.) Together, the team trained a deep-learning model called DrugReflector on publicly available data about how each of nearly 9,600 chemical compounds perturbs gene activity in more than 50 kinds of cells.<\/p>\n<p>They used DrugReflector to find chemicals that can affect the generation of platelets and red blood cells \u2014 a characteristic that could be useful in treating some blood conditions. They then tested 107 of these chemicals to determine whether they had the predicted effect. <\/p>\n<p>Overall, the team found that DrugReflector was up to 17 times more effective at finding relevant compounds than standard, brute-force drug screening that depends on randomly selecting compounds from a chemical library. And when the researchers circled back to incorporate the data from their first round of screening into the model, its success rate doubled.<\/p>\n","protected":false},"excerpt":{"rendered":"An artificial-intelligence method that incorporates gene-expression data could help to speed up drug discovery.Credit: Qilai Shen\/Bloomberg\/Getty An artificial&hellip;\n","protected":false},"author":3,"featured_media":328682,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[24304,10046,8523,10047,159,67,132,68],"class_list":{"0":"post-328681","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-science","8":"tag-drug-discovery","9":"tag-humanities-and-social-sciences","10":"tag-machine-learning","11":"tag-multidisciplinary","12":"tag-science","13":"tag-united-states","14":"tag-unitedstates","15":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115428238796851049","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/328681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=328681"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/328681\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/328682"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=328681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=328681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=328681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}